Last reviewed · How we verify
NCT06614218
MIMS® Retrospective Chart Review
trial testing Minimally Invasive Micro Sclerostomy in Open Angle Glaucoma in 40 participants. Not yet recruiting.
1 January 2026
Quick facts
| Lead sponsor | Sanoculis Ltd |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 1 February 2025 |
| Primary completion | 1 January 2026 |
| Estimated completion | 1 January 2026 |
| Sites | 1 location across Armenia |
Drugs / interventions tested
- Minimally Invasive Micro Sclerostomy
Conditions studied
- Open Angle Glaucoma — all drugs for Open Angle Glaucoma →
Sponsor
Sanoculis Ltd
Who can join
Adults 40 to 85, any sex, with Open Angle Glaucoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a post-market clinical follow-up, retrospective chart review of MIMS® surgical procedures conducted during time period between Sep 2023 and May 2025.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06614218
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Minimally Invasive Micro Sclerostomy
Trials testing the same drug.
- NCT02355990 — Minimally Invasive Micro Sclerostomy First in Man Safety and Preliminary Performance Study · NA · completed
Other recruiting trials for Open Angle Glaucoma
Currently open trials in the same condition.
- NCT07228221 — Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma · Phase 4 · recruiting
- NCT06883123 — Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost · Phase 4 · recruiting
- NCT06666855 — A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China · Phase 3 · active not recruiting
- NCT06246136 — Comparative Effectiveness and Safety of ELIOS in Patients With Open-Angle Glaucoma Undergoing Cataract Surgery · NA · recruiting
- NCT06061718 — Travoprost Intraocular Implant in Conjunction With Cataract Surgery · Phase 3 · active not recruiting
Other Sanoculis Ltd trials
Trials by the same sponsor.
- NCT07081347 — This Follow-up Extension Study is Aimed to Monitor the Long-term IOP-lowering Performance/Efficacy and Safety of the MIN · NA · active not recruiting
- NCT06577857 — Inferonasal MIMS® Procedure: Long-Term Follow-Up Extension Study · recruiting
- NCT06612346 — Minimally Invasive Nasal Trabeculostomy: Long-Term Follow-Up Extension Study · completed
- NCT05638321 — Minimally Invasive Micro Sclerostomy (MIMS®) Inferonasal Procedure - Performance Evaluation Study · NA · completed
- NCT07051174 — The Minimally Invasive Micro Sclerostomy (MIMS®) System is Intended for the Reduction of Elevated Intraocular Pressure ( · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06614218 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sanoculis Ltd
- Last refreshed: 10 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06614218.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing